1-10 of 10
Rinku Pal
Close
Sort by
Journal Articles

Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses

Konstantinos Aliazis, Anthos Christofides, Halil-Ibrahim Aksoylar, Rushil Shah, Rinku Pal, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2023) 142 (Supplement 1): 2551.
https://doi.org/10.1182/blood-2023-174422
Published: 2023
Journal Articles

Pparβ/δ Has an Indispensable Role in T Cell Function and Anti-Tumor Responses

Betul Ibis, Anthos Christofides, Konstantinos Aliazis, Rushil Shah, Rinku Pal, Vassiliki A Boussiotis
Journal: Blood
Blood (2023) 142 (Supplement 1): 1180.
https://doi.org/10.1182/blood-2023-174450
Published: 2023
Journal Articles

Targeted Deletion of Pparβ/δ in Myeloid Cells Enhances Their Tumor-Promoting Function

Anthos Christofides, Rinku Pal, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2023) 142 (Supplement 1): 3908.
https://doi.org/10.1182/blood-2023-178186
Published: 2023
Journal Articles

PD-1 Expression By Dendritic Cells Is a Key Regulator of T-Cell Immunity in Cancer

Rushil Shah, Konstantinos Aliazis, Anthos Christofides, Angelique A Pham, Rinku Pal, Vassiliki A Boussiotis
Journal: Blood
Blood (2023) 142 (Supplement 1): 2538.
https://doi.org/10.1182/blood-2023-178180
Published: 2023
Journal Articles

SHP-2 Regulates Myeloid Cell Differentiation, Anti-Tumor Responses and Innate Immune Memory

Anthos Christofides, Xanthi-Leda Katopodi, Carol Cao, Dimitra Karagkouni, Konstantinos Aliazis, Sasitorn Yenyuwadee, Rinku Pal, John Asara, Ioannis Vlachos, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2022) 140 (Supplement 1): 1403–1404.
https://doi.org/10.1182/blood-2022-170307
Published: 2022
Journal Articles

Loss of the Nuclear Receptor Pparγ Primes T Effector (T EFF ) Differentiation of Antigen-Specific CD8 + T Cells

Rushil Shah, Xanthi-Leda Katopodi, Anthos Christofides, Rinku Pal, Ioannis Vlachos, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2022) 140 (Supplement 1): 2637–2638.
https://doi.org/10.1182/blood-2022-170612
Published: 2022
Journal Articles

Pparα Ablation Suppresses T Cell Responses and Anti-Tumor Immunity By Compromising the Antigen-Presenting Properties of Tumor-Associated Macrophages

Anthos Christofides, Carol Cao, Qi Wang, Natalia M Tijaro-Ovalle, Eirini Konstantinidou, Rushil Shah, Chinmay Jani, Rinku Pal, Halil-Ibrahim Aksoylar, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2021) 138 (Supplement 1): 438.
https://doi.org/10.1182/blood-2021-149071
Published: 2021
Journal Articles

Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade

Anthos Christofides, MD, Natalia M Tijaro-Ovalle, MD, Halil-Ibrahim Aksoylar, PhD, Rinku Pal, MS, Abdelrahman AA Mahmoud, Laura Strauss, PhD, Nikolaos Patsoukis, PhD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-138975
Published: 2020
Journal Articles

The Rap1-RIAM Pathway Regulates the Expression of Integrins αEβ7(CD103) and α4β7, Which Guide T Cell Homing to Intestinal Compartments

Yavuz-Furkan Yazicioglu, Halil-Ibrahim Aksoylar, PhD, Rinku Pal, MS, Nikolaos Patsoukis, PhD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 864.
https://doi.org/10.1182/blood-2018-99-119450
Published: 2018
Journal Articles

Metabolic Reprogramming of Myeloid Cells in Response to Factors of "Emergency" Myelopoiesis By Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate Commitment and Anti-Tumor Immunity

Laura Strauss, PhD, Jessica D Weaver, PhD, Rinku Pal, MS, John Asara, PhD, Nikolaos Patsoukis, PhD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 14.
https://doi.org/10.1182/blood-2018-99-117438
Published: 2018